SCHEMBL24065770

SCHEMBL24065770

N#Cc1cc(C#N)cc(-c2ccc(-c3ccc(-c4nc(-c5ccccc5)c5ccccc5n4)c4ccccc34)cc2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 7/20 0.50
KMT2A Q03164 7/20 0.50
ADORA2A P29274 3/20 0.50
ATM Q13315 1/20 0.50
CYP1A2 P05177 8/20 0.44
CYP3A4 P08684 7/20 0.44
LMNA P02545 6/20 0.44
ALDH1A1 P00352 5/20 0.44
CYP2D6 P10635 5/20 0.44
CLK4 Q9HAZ1 4/20 0.44
HSD17B10 Q99714 4/20 0.44
CYP2C19 P33261 3/20 0.44
TSHR P16473 3/20 0.44
MAPK1 P28482 3/20 0.44
CYP2C9 P11712 2/20 0.44
TP53 P04637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
MAPT P10636 1/20 0.44
USP2 O75604 3/20 0.41
ALOX15 P16050 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24065763 1.00 MEN1 (0.50) MEN1KMT2AADORA2AATMCYP1A2
SCHEMBL24065767 0.93 ADORA2A (0.46) MEN1KMT2AADORA2AATMCYP1A2
SCHEMBL24065741 0.91 MEN1 (0.50) MEN1KMT2AADORA2AATMCYP1A2
SCHEMBL24065766 0.91 MEN1 (0.50) MEN1KMT2AADORA2AATMCYP1A2
SCHEMBL24065764 0.91 ADORA2A (0.46) MEN1KMT2AADORA2AATMCYP1A2
SCHEMBL24065818 0.90 CYP1A2 (0.50) MEN1KMT2AADORA2AATMCYP1A2
SCHEMBL24065802 0.90 CYP1A2 (0.50) MEN1KMT2AADORA2AATMCYP1A2
SCHEMBL22652757 0.90 MEN1 (0.62) MEN1KMT2AADORA2AATMCYP1A2
SCHEMBL24065765 0.88 ADORA2A (0.44) MEN1KMT2AADORA2AATMCYP1A2
SCHEMBL24065803 0.88 ADORA2A (0.44) MEN1KMT2AADORA2AATMCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210376253-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-12-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210376253-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME TRPC4, CRY1, TRPC1 MEN1 780/4885KMT2A 2776/4885ADORA2A 3738/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.